Vitamin C linked to fewer deaths in blood disorder trial

In a phase 2 trial of people with precancerous or low-risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow-up also found fewer deaths among participants taking vitamin C than among those receiving placebo.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.